Potential voriconazole and caspofungin sequestration during extracorporeal membrane oxygenation

Intensive Care Med. 2009 Jan;35(1):183-4. doi: 10.1007/s00134-008-1269-3. Epub 2008 Sep 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antifungal Agents / pharmacokinetics*
  • Caspofungin
  • Echinocandins / blood
  • Echinocandins / pharmacokinetics*
  • Extracorporeal Membrane Oxygenation / adverse effects*
  • Female
  • Humans
  • Lipopeptides
  • Lung Diseases, Fungal / drug therapy
  • Myocarditis / complications
  • Pyrimidines / blood
  • Pyrimidines / pharmacokinetics*
  • Shock, Cardiogenic / etiology
  • Shock, Cardiogenic / therapy
  • Triazoles / blood
  • Triazoles / pharmacokinetics*
  • Voriconazole

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Pyrimidines
  • Triazoles
  • Caspofungin
  • Voriconazole